Close Menu

NEW YORK – The National Institutes of Health said this week that the Accelerating Medicines Partnership (AMP) program for Parkinson's disease has launched a data portal to provide researchers with de-identified information collected from 4,298 Parkinson's patients and healthy controls. The portal can be used to develop therapies for the disease, study complex data sets, and perform genome-wide analyses at a large scale.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.